About PharmaNutra
PharmaNutra is a publicly listed company based in Pisa (Italy) founded in 2003 by Andrea Lacorte. Nutraceutical and pharmaceutical products are developed in Italy. PharmaNutra has completed 1 acquisition, including Akern. Its chief executive, as recorded, is Andrea Lacorte. Its website pharmanutra.it draws about 26 thousand monthly visits. Its focus areas include Traditional Nutraceuticals and Diversified.
Company details
Pharmanutra was founded in 2003 in Pisa, Italy, and operates within the nutraceutical and pharmaceutical sectors. Nutritional supplements and medical devices are developed with a focus on efficacy and safety for various age groups. The entire production process is managed, from raw material sourcing to marketing. Investments are made in research and development, with intellectual property protected through proprietary raw materials and technologies.
- Headquarters Pisa, Italy
- Founders Andrea Lacorte
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website pharmanutra.it/it
- Social LinkedIn X Facebook
- Legal Name Pharmanutra S.P.A.
- Annual Revenue$154.74 M (USD)14.02as on Dec 31, 2025
- Net Profit$23.5 M (USD)20.44as on Dec 31, 2025
- EBITDA$37.93 M (USD)7.07as on Dec 31, 2025
- Investments & Acquisitions
People of PharmaNutra
27 people are tracked at PharmaNutra (7 in leadership, 20 in team).
| Name | Role | Group |
|---|---|---|
Andrea Lacorte | Founder & CEO | Leadership |
Carlo Volpi | COO | Leadership |
Eleonora Casarosa | Head Of Legal & Corporate Affairs | Leadership |
Andrea Tomarchio | Area General Manager | Leadership |
Francesco Sarti | CFO | Leadership |
Germano Tarantino | Chief Scientific Officer | Leadership |
Guido Carugi | President: Michele Luigi Giordano | Leadership |
Carolina Pasero | Field Force Trainer Supervisor | Team |
Alessandra Cini | Esg | Team |
Sara la Mastra | Export Manager | Team |
Radu Draghici | Informatore/agente Di Commercio | Team |
Irene Lacorte | Junior Recruiter | Team |
Virginia Montella | Field Force Trainer | Team |
Veronica Picchi | Medical Sales Representative | Team |
Claudia Bargagna | Senior HR Recruiter | Team |
Simone Antonetti | IT Application Specialist | Team |
Francesco Cognetti | IT Manager | Team |
Roberto Ruglioni | Information Technology Infrastructure Specialist | Team |
Michele Magara | Controller | Team |
Giuseppe Cisterna | Group Controller | Team |
7 more people are available in the full profile.
Complete people profiles for PharmaNutra
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of PharmaNutra
PharmaNutra is a publicly listed company on the MIL with ticker symbol PHN in Italy, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Jul 2017
- Listed onMIL: PHN
- Listed entityPharmaNutra S.p.A.
- Exchange sectorHealth technology
- ISINIT0005274094
- Share price71.20 EUR · 2026-10-14
- Market capitalisation689,285,523.00 EUR
- Price to earnings32.9
- EPS (diluted, trailing year)2.17 EUR
- Dividend yield1.69%
- Volume (last session)294
Financials of PharmaNutra
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 131.7M EUR | 20.0M EUR | 32.3M EUR |
| 2024 | 115.5M EUR | 16.6M EUR | 30.1M EUR |
| 2023 | 100.2M EUR | 12.8M EUR | 24.9M EUR |
| 2022 | 82.7M EUR | 15.1M EUR | 23.8M EUR |
| 2021 | 68.1M EUR | 13.8M EUR | 19.4M EUR |
Detailed financial statements for PharmaNutra
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PharmaNutra
PharmaNutra has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Akern.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Bioimpedance analyzers and software are developed for body composition assessment. | akern.com | Pisa, Italy | 1980 | Jun 2022 | $12.51M |
Complete acquisition details for PharmaNutra
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PharmaNutra
3 dated milestones of PharmaNutra across 19 years, from founding to its latest funding, stage changes and deals.
- Founded PharmaNutra is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Akern.
Web traffic of PharmaNutra
The website of PharmaNutra (pharmanutra.it) receives about 26.1K visits a month and ranks #1,132,593 among all websites worldwide, #1,400 in Biotechnology and Pharmaceuticals.
- Monthly visits26.1K
▲ 14.4% vs previous month
- Unique visitors11.2K
per month
- Global rank#1,132,593
among all websites
- Category rank#1,400
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit2.2
- Average visit48 sec
- DevicesDesktop 30% · Mobile 70%
Websites whose visitors overlap most with PharmaNutra. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ibsa.ch | 100% | #4,302,558 | View details | ||
farmaciabrembate.it | farmaciabrembate.it | 74% | #1,444,274 | – | |
nutramfg.com | nutramfg.com | 70% | – | ||
pharmalab24.com | pharmalab24.com | 66% | #2,797,988 | – | |
spaziopharma.it | spaziopharma.it | 65% | #2,577,267 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 37 similar websites and full traffic analytics for PharmaNutra
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 37 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pharmanutra
Complete news archive for PharmaNutra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmaNutra
PharmaNutra was founded in 2003.
PharmaNutra is headquartered in Pisa, Italy. It is registered at Pisa, Tuscany, Italy.
Andrea Lacorte is the CEO of PharmaNutra, as recorded in our data. They have also founded this company.
Annual revenue of PharmaNutra is $154.74M as on Dec 31, 2025.
Pharmanutra was founded in 2003 in Pisa, Italy, and operates within the nutraceutical and pharmaceutical sectors. Nutritional supplements and medical devices are developed with a focus on efficacy and safety for various age groups. The entire production process is managed, from raw material sourcing to marketing. Investments are made in research and development, with intellectual property protected through proprietary raw materials and technologies.
Yes, PharmaNutra is publicly traded on MIL under the ticker symbol PHN.
PharmaNutra has made 1 acquisition, including Akern.